Skip to main content
Healthcare

STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds

STAT+: Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds

Feed excerpt — reported by STAT News

Nearly 40% of FDA advisory committee meetings over a 20-year period included either a patient or consumer rep with active ties to an advocacy group funded by pharma companies.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.